2026-01-12 - Analysis Report
# Comprehensive Analysis

## Company Overview
Transmedics Group Inc, reviewed under ticker TMDX, is a company involved in organ transplantation.

### Financial Analysis 

### Comparison of Return Rates
- Return rate of the review stock (TMDX) = 234.42%
- Return rate of the comparison stock (VOO) = 73.79%
- Degree of divergence (simply the difference in cumulative return on the last day of the data) = 160.60

### Alpha and Beta Analysis
|   | 2020-2022 | 2021-2023 | 2022-2024 | 2023-2025 |
| - | - | - | - | - |
| CAGR     | 94.0% | 65.0% | 130.0% | 120.0%  |
| MDD      | 60.2% | 60.2% | 51.7%   | 53.4%   |
| Alpha    | 96.0% | 64.0% | 111.0%  | 58.0%   |
| Beta     | 1.3    | 1.7    | 1.8      | 1.4     |
| Cap(B)   | 2.1B   | 2.7B   | 2.1B     | 4.2B    |

### Recent Stock Price Fluctuations
- Close = $137.07
- Last-market price change = -0.36
- 5-day SMA = $134.17
- 20-day SMA = $127.11
- 60-day SMA = $128.13

### Stock Risk Level and Indicators Analysis

- Market Risk Indicator (MRI) = 0.70 (Medium Investment)
- RSI = 74.69
- PPO = 1.20
- Hybrid Signal: Buy (Risk Level: Medium)
- Recent (20 days) relative divergence change = 9.80 (+): improving
- 7-day Rank change = -2 (-): rank down, 7-day Dynamic Expected Return change = -13.80 (-): worsening
- Expected Return (%) = 42.60%

### News and Significant Events
- [2025-12-27] "Here Are My Top 2 No-Brainer Growth Stocks to Buy Now"
- [2026-01-10] "TransMedics Group, Inc. $TMDX Stock Position Raised by Peregrine Capital Management LLC"
- [2025-10-30] "TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y"
- [2026-01-07] "Does TransMedics (TMDX) Logistics Integration Reframe Its Risk Reward Profile In Organ Transplantation?"
- [2026-01-09] "3 MedTech Stocks That Crushed the S&P 500 Over the Past Year"
- [2025-12-22] "TransMedics stock could see upside from heart trial, Piper Sandler says"

### Analyst Opinions
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.67
- Opinions: 11
- Target Price (avg/high/low): 144.73 / 170.00 / 114.00

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.